What Is a Peptide? Peptides vs Proteins, Hormones and Small Molecules

“Peptide” describes a molecular form, not a therapeutic effect, safety profile or level of evidence. The label is often stretched in online discussion to include proteins, modified analogues, amino-acid derivatives and unrelated small molecules. Clear classification prevents weak claims from borrowing credibility from an entire field.

Peptides

Peptides are chains of amino acids joined by peptide bonds. There is no single universal length cut-off separating a peptide from a protein; conventions vary by discipline. Sequence, structure, post-translational modifications and three-dimensional folding often matter more than a simple residue count.

Proteins

Proteins are generally longer polypeptides that adopt organised structures and carry out biological functions. Some are composed of multiple chains. The peptide–protein boundary is therefore a practical convention rather than a natural switch.

Hormones

“Hormone” describes a signalling role, not a chemical class. Some hormones are peptides or proteins, while others are steroids, amino-acid derivatives or other molecules. Insulin is a peptide hormone; cortisol is a steroid hormone. Calling something a hormone tells you about biological communication, not its complete chemistry.

A concrete example: GLP-1 is a peptide hormone, while “GLP-1 receptor agonist” describes activity at its receptor. A medicine with that activity can be a modified peptide such as semaglutide or a non-peptide small molecule such as orforglipron. The FDA orforglipron review illustrates that distinction. Read what GLP-1 means and how receptor agonists differ from the hormone for the full explanation.

Peptidomimetics and modified analogues

Researchers often modify natural sequences to change stability, receptor selectivity, half-life or delivery. A peptide analogue may include non-natural amino acids, lipidation, cyclisation or other engineering. Its evidence cannot be assumed from the natural peptide it resembles.

Small molecules

Small molecules are lower-molecular-weight compounds that are not amino-acid chains. 5-amino-1MQ and SLU-PP-332, for example, are frequently grouped into “peptide” catalogues online despite being experimental small molecules. Their mechanisms and evidence must be assessed on their own terms.

Why classification matters

• Analytical methods: identity and impurity testing depend on molecular properties.
• Delivery and stability: susceptibility to enzymes, aggregation and membrane permeability vary.
• Regulation: legal classification depends on intended use, claims, formulation and jurisdiction—not just a label.
• Evidence: activity in a receptor assay is not equivalent to an outcome in a randomised human trial.

A better reading sequence

1. Confirm the molecule’s identity and aliases.
2. Identify the proposed target or pathway.
3. Separate cell, animal and human evidence.
4. Check registered trials and published results.
5. Verify current regulatory status in the relevant country.
6. State uncertainty and the date checked.

Use the Research Library to see these principles applied to individual compounds, including profiles that correct common category errors.